Login
Home
Charts
Search
Watchlist
Products

Sanofi India Ltd

SANOFI·NSE
3,052.40-0.21%Wed, 23 Sept '26 15:52

Sanofi India Ltd

SANOFI
NSE
3,052.40
-0.21%
|Wed, 23 Sept '26 15:52
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
7,047Cr
Close
Close Price
3,060.00
Industry
Industry
Pharma - MNC bulk Drugs
PE
Price To Earnings
21.77
PS
Price To Sales
3.90
Revenue
Revenue
1,805Cr
Rev Gr TTM
Revenue Growth TTM
-8.88%
PAT Gr TTM
PAT Growth TTM
-10.68%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
491469511464524515536406475420472438
Growth YoY
Revenue Growth YoY%
-29.1-30.2-30.6-10.06.89.74.9-12.3-9.3-18.5-11.97.7
Expenses
ExpensesCr
377370374348404397364311341330330322
Operating Profit
Operating ProfitCr
1141001371161201181729513490143115
OPM
OPM%
23.121.226.825.022.823.032.123.428.221.530.226.3
Other Income
Other IncomeCr
119-23-1421439-22346
Interest Expense
Interest ExpenseCr
000000000100
Depreciation
DepreciationCr
999991010991099
PBT
PBTCr
11599105921131221659410283138112
Tax
TaxCr
343033243031462526213529
PAT
PATCr
152138137103829112070766210384
Growth YoY
PAT Growth YoY%
16.35.2-28.3-15.9-46.0-33.7-12.5-32.8-7.5-32.4-14.120.1
NPM
NPM%
31.029.426.722.315.717.722.317.116.014.721.719.1
EPS
EPS
66.159.959.344.935.739.651.930.233.026.844.536.3
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
491469511464524515536406475420472438
Growth YoY
Revenue Growth YoY%
-29.1-30.2-30.6-10.06.89.74.9-12.3-9.3-18.5-11.97.7
Expenses
ExpensesCr
377370374348404397364311341330330322
Operating Profit
Operating ProfitCr
1141001371161201181729513490143115
OPM
OPM%
23.121.226.825.022.823.032.123.428.221.530.226.3
Other Income
Other IncomeCr
119-23-1421439-22346
Interest Expense
Interest ExpenseCr
000000000100
Depreciation
DepreciationCr
999991010991099
PBT
PBTCr
11599105921131221659410283138112
Tax
TaxCr
343033243031462526213529
PAT
PATCr
152138137103829112070766210384
Growth YoY
PAT Growth YoY%
16.35.2-28.3-15.9-46.0-33.7-12.5-32.8-7.5-32.4-14.120.1
NPM
NPM%
31.029.426.722.315.717.722.317.116.014.721.719.1
EPS
EPS
66.159.959.344.935.739.651.930.233.026.844.536.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025TTM
Revenue
RevenueCr
2,1932,3672,4642,7713,0712,9022,9572,7702,8512,0131,8371,805
Growth
Revenue Growth%
10.97.94.112.510.8-5.51.9-6.32.9-29.4-8.7-8.9
Expenses
ExpensesCr
1,7341,8321,9262,1472,4052,1892,1942,0662,0471,5221,3461,323
Operating Profit
Operating ProfitCr
459535537624665713763704804491491483
OPM
OPM%
20.922.621.822.521.724.625.825.428.224.426.726.7
Other Income
Other IncomeCr
51668190354856420483-21-8-9
Interest Expense
Interest ExpenseCr
021102222222
Depreciation
DepreciationCr
11311910210310082674240373737
PBT
PBTCr
3974805156106006771,258864846431445436
Tax
TaxCr
159176189229186200313244243118118112
PAT
PATCr
238304326381414478944621603314327324
Growth
PAT Growth%
20.628.07.216.88.815.397.7-34.3-2.8-48.04.1-10.7
NPM
NPM%
10.812.813.213.713.516.531.922.421.215.617.817.9
EPS
EPS
139.6132.3141.7165.5179.8207.4410.1269.5261.9179.5141.8140.6
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025TTM
Revenue
RevenueCr
2,1932,3672,4642,7713,0712,9022,9572,7702,8512,0131,8371,805
Growth
Revenue Growth%
10.97.94.112.510.8-5.51.9-6.32.9-29.4-8.7-8.9
Expenses
ExpensesCr
1,7341,8321,9262,1472,4052,1892,1942,0662,0471,5221,3461,323
Operating Profit
Operating ProfitCr
459535537624665713763704804491491483
OPM
OPM%
20.922.621.822.521.724.625.825.428.224.426.726.7
Other Income
Other IncomeCr
51668190354856420483-21-8-9
Interest Expense
Interest ExpenseCr
021102222222
Depreciation
DepreciationCr
11311910210310082674240373737
PBT
PBTCr
3974805156106006771,258864846431445436
Tax
TaxCr
159176189229186200313244243118118112
PAT
PATCr
238304326381414478944621603314327324
Growth
PAT Growth%
20.628.07.216.88.815.397.7-34.3-2.8-48.04.1-10.7
NPM
NPM%
10.812.813.213.713.516.531.922.421.215.617.817.9
EPS
EPS
139.6132.3141.7165.5179.8207.4410.1269.5261.9179.5141.8140.6

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025Jun 2026
Equity Capital
Equity CapitalCr
232323232323232323232323
Reserves
ReservesCr
1,6041,8602,0032,1962,4192,0962,2031,253993838726803
Current Liabilities
Current LiabilitiesCr
617502602624703687750741651737491570
Non Current Liabilities
Non Current LiabilitiesCr
16115615014199113865548151411
Total Liabilities
Total LiabilitiesCr
2,4052,5412,7782,9843,2442,9193,0612,0721,7151,6121,2551,407
Current Assets
Current AssetsCr
1,2441,5751,4441,5922,1291,8332,1381,6101,2461,127801965
Non Current Assets
Non Current AssetsCr
1,1619661,3341,3921,1151,085923461469485454442
Total Assets
Total AssetsCr
2,4052,5412,7782,9843,2442,9193,0612,0721,7151,6121,2551,407
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025Jun 2026
Equity Capital
Equity CapitalCr
232323232323232323232323
Reserves
ReservesCr
1,6041,8602,0032,1962,4192,0962,2031,253993838726803
Current Liabilities
Current LiabilitiesCr
617502602624703687750741651737491570
Non Current Liabilities
Non Current LiabilitiesCr
16115615014199113865548151411
Total Liabilities
Total LiabilitiesCr
2,4052,5412,7782,9843,2442,9193,0612,0721,7151,6121,2551,407
Current Assets
Current AssetsCr
1,2441,5751,4441,5922,1291,8332,1381,6101,2461,127801965
Non Current Assets
Non Current AssetsCr
1,1619661,3341,3921,1151,085923461469485454442
Total Assets
Total AssetsCr
2,4052,5412,7782,9843,2442,9193,0612,0721,7151,6121,2551,407

Cash Flow

Consolidated
Standalone
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow
Operating Cash FlowCr
213322435374412611559399231462438
Investing Cash Flow
Investing Cash FlowCr
36-155-79-736627663165136-19-11
Financing Cash Flow
Financing Cash FlowCr
-147-180-188-197-183-810-849-1,583-878-392-448
Net Cash Flow
Net Cash FlowCr
102-1316810429578341-533-61250-21
Free Cash Flow
Free Cash FlowCr
185253379317337810574412221426413
CFO To PAT
CFO To PAT%
89.7105.9133.598.299.5128.059.264.238.3147.2134.2
CFO To EBITDA
CFO To EBITDA%
46.460.281.060.062.085.773.356.628.794.189.2
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow
Operating Cash FlowCr
213322435374412611559399231462438
Investing Cash Flow
Investing Cash FlowCr
36-155-79-736627663165136-19-11
Financing Cash Flow
Financing Cash FlowCr
-147-180-188-197-183-810-849-1,583-878-392-448
Net Cash Flow
Net Cash FlowCr
102-1316810429578341-533-61250-21
Free Cash Flow
Free Cash FlowCr
185253379317337810574412221426413
CFO To PAT
CFO To PAT%
89.7105.9133.598.299.5128.059.264.238.3147.2134.2
CFO To EBITDA
CFO To EBITDA%
46.460.281.060.062.085.773.356.628.794.189.2

Ratios

Consolidated
Standalone
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
10,0369,89610,85714,63016,15719,15618,17813,47218,57914,0979,4237,047
Price To Earnings
Price To Earnings
31.232.533.338.439.040.119.221.730.834.028.821.8
Price To Sales
Price To Sales
4.64.24.45.35.36.66.24.96.57.05.13.9
Price To Book
Price To Book
6.25.35.36.66.69.08.210.618.316.412.68.5
EV To EBITDA
EV To EBITDA
20.617.418.922.122.625.221.817.722.628.218.713.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
49.150.555.154.252.252.952.853.954.749.149.249.2
OPM
OPM%
20.922.621.822.521.724.625.825.428.224.426.726.7
NPM
NPM%
10.812.813.213.713.516.531.922.421.215.617.817.9
ROCE
ROCE%
24.425.625.427.524.631.756.066.781.949.258.252.9
ROE
ROE%
14.616.216.117.117.022.542.448.659.436.543.639.2
ROA
ROA%
9.912.011.712.812.816.430.930.035.219.526.023.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
10,0369,89610,85714,63016,15719,15618,17813,47218,57914,0979,4237,047
Price To Earnings
Price To Earnings
31.232.533.338.439.040.119.221.730.834.028.821.8
Price To Sales
Price To Sales
4.64.24.45.35.36.66.24.96.57.05.13.9
Price To Book
Price To Book
6.25.35.36.66.69.08.210.618.316.412.68.5
EV To EBITDA
EV To EBITDA
20.617.418.922.122.625.221.817.722.628.218.713.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
49.150.555.154.252.252.952.853.954.749.149.249.2
OPM
OPM%
20.922.621.822.521.724.625.825.428.224.426.726.7
NPM
NPM%
10.812.813.213.713.516.531.922.421.215.617.817.9
ROCE
ROCE%
24.425.625.427.524.631.756.066.781.949.258.252.9
ROE
ROE%
14.616.216.117.117.022.542.448.659.436.543.639.2
ROA
ROA%
9.912.011.712.812.816.430.930.035.219.526.023.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Sanofi India Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/tew5foz33oh5mj2lb6ulcmvp.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/3zinvhyue9ja18upnsm259gh.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/o7nf1rgkqoo33wk1gddgghfu.pdf
  • Q4 FY2024 Earnings Call Transcript (Mar 2024, PDF): https://www.stockscans.in/document/rv0q0w9ia6a8haajdkqm2ll8.pdf
  • Q3 FY2024 Earnings Call Transcript (Dec 2023, PDF): https://www.stockscans.in/document/zaygyu3iv15svuogqxi5pwnb.pdf
  • Q2 FY2024 Earnings Call Transcript (Sep 2023, PDF): https://www.stockscans.in/document/2sapiawydhv6hflml336iyap.pdf
  • Q4 FY2023 Earnings Call Transcript (Mar 2023, PDF): https://www.stockscans.in/document/ah8rdqdwf3eccynopib11t4x.pdf
  • Q3 FY2023 Earnings Call Transcript (Dec 2022, PDF): https://www.stockscans.in/document/x1ihyjmg7a7pmlikdwlifefc.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/p1dilxi3nb6e9funlh987ugn.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/dz0fg1nu52ozsnz16x844o3n.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/r17qtfwrca3o0g56nh6ml81p.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/58slnl0y2iyiy4net2g9jt08.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/39eypfr2u0ls64lsoas3ikpp.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/z4m3hl3f36hzgfw0rrrph9nz.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/02afxyaubani2c2audou1n9e.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/qgiu6zdt77w0un0r9ekct37c.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/lxj2j3vjo2qditd7poai0o6g.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/6mrjjukmhpeci7smp7vag8q4.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/20pi4cc36wafzl5dpugx39so.pdf
  • Q4 FY2024 Investor Presentation (Mar 2024, PDF): https://www.stockscans.in/document/zwnmplxvqur1bupewgqhngrn.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/yvee0ayapslcdp47mby4o2jo.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/lpt8ab5p7t5cqgrinjuvvcgl.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/qy2xd0l4rrak2wjh8gkaydog.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/mcqwrl7amjpvo1cbmq9z5dw1.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/kfgij5yjwfij32boybmp8uwu.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/crt89vyumu1c6yrs80t81oo6.pdf

Concall Transcript Summaries — Sanofi India Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3ASANOFI/transcript-notes/202606/tew5foz33oh5mj2lb6ulcmvp.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3ASANOFI/transcript-notes/202512/3zinvhyue9ja18upnsm259gh.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3ASANOFI/transcript-notes/202509/o7nf1rgkqoo33wk1gddgghfu.pdf
  • Q4 FY2024 Concall Transcript Summary (Mar 2024): https://www.stockscans.in/company/NSE%3ASANOFI/transcript-notes/202403/rv0q0w9ia6a8haajdkqm2ll8.pdf
  • Q3 FY2024 Concall Transcript Summary (Dec 2023): https://www.stockscans.in/company/NSE%3ASANOFI/transcript-notes/202312/zaygyu3iv15svuogqxi5pwnb.pdf
  • Q2 FY2024 Concall Transcript Summary (Sep 2023): https://www.stockscans.in/company/NSE%3ASANOFI/transcript-notes/202309/2sapiawydhv6hflml336iyap.pdf
  • Q4 FY2023 Concall Transcript Summary (Mar 2023): https://www.stockscans.in/company/NSE%3ASANOFI/transcript-notes/202303/ah8rdqdwf3eccynopib11t4x.pdf
  • Q3 FY2023 Concall Transcript Summary (Dec 2022): https://www.stockscans.in/company/NSE%3ASANOFI/transcript-notes/202212/x1ihyjmg7a7pmlikdwlifefc.pdf